• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    1/19/24 2:40:53 PM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email
    SC 13G/A 1 us00773t1016_011924.txt us00773t1016_011924.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) ADVANSIX INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 00773T101 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 00773T101 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 4832850 (6) Shared voting power 0 (7) Sole dispositive power 4905819 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 4905819 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 18.2% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- ADVANSIX INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 300 KIMBALL DRIVE SUITE 101 PARSIPPANY NJ 07054 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 50 Hudson Yards New York, NY 10001 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) CUSIP No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 4905819 Percent of class 18.2% Number of shares as to which such person has: Sole power to vote or to direct the vote 4832850 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 4905819 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The interest of 1 such person, iShares Core S&P Small-Cap ETF, in the common stock of ADVANSIX INC is more than five percent of the total outstanding common stock. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 19, 2024 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary BlackRock Advisors, LLC Aperio Group, LLC BlackRock (Netherlands) B.V. BlackRock Fund Advisors* BlackRock Institutional Trust Company, National Association BlackRock Asset Management Ireland Limited BlackRock Financial Management, Inc. BlackRock Asset Management Schweiz AG BlackRock Investment Management, LLC BlackRock Investment Management (UK) Limited BlackRock Asset Management Canada Limited BlackRock Investment Management (Australia) Limited BlackRock Fund Managers Ltd *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BlackRock, Inc., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Daniel Goldmintz, Laura Hildner, Elizabeth Kogut, David Maryles, Christopher Meade, Una Neary, Charles Park, Daniel Riemer, David Rothenberg and Brenda Schulz, acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing, in its name and on its behalf and on behalf of its direct and indirect subsidiaries, any and all documents, certificates, instruments, statements, filings, agreements and amendments (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Schedules 13D and 13G and Forms 3, 4, 5, 13F and 13H and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental or regulatory authority or other person, and giving and granting to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as the Company and/or its direct and indirect subsidiaries, as applicable, might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 2nd day of January, 2019 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 30th day of April, 2023. BlackRock, Inc. By: /s/ R. Andrew Dickson, III Name: R. Andrew Dickson, III Title: Corporate Secretary
    Get the next $ASIX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    SEC Filings

    View All

    AdvanSix Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AdvanSix Inc. (0001673985) (Filer)

    9/2/25 4:21:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form 144 filed by AdvanSix Inc.

    144 - AdvanSix Inc. (0001673985) (Subject)

    8/1/25 5:16:01 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by AdvanSix Inc.

    10-Q - AdvanSix Inc. (0001673985) (Filer)

    8/1/25 4:10:40 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Dana O'Brien and Daryl Roberts as new independent members of its Board of Directors. Ms. O'Brien recently retired as Senior Vice President and Chief Legal Officer of Olin Corporation, a leading vertically integrated global manufacturer and distributor of chemical products. Ms. O'Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee of the Board. Mr. Roberts is currently Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc., a global innovation leader with technology-based materials and solutions t

    9/2/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Announces Second Quarter 2025 Financial Results

    2Q25 Sales of $410 million, down 10% versus prior year 2Q25 Earnings Per Share of $1.15; Adjusted Earnings Per Share of $1.24 2Q25 Cash Flow from Operations of $21 million $8 million of 45Q carbon capture tax credits claimed in 2Q25 AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the second quarter ending June 30, 2025. Overall, the Company delivered resilient earnings with strong sequential improvement and executed key growth and enterprise initiatives to support long-term sustainable performance. Second Quarter 2025 Summary "Our resilient second quarter results reflect our collective organization's execution and the advantages of

    8/1/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Second Quarter Financial Results and Hold Investor Conference Call on August 1

    AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its second quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, August 1. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's second quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on August 1 until 12 noon ET on August 8. You can listen to the replay by dialing (87

    7/11/25 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AdvanSix upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

    5/19/25 8:45:52 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

    4/7/25 8:48:39 AM ET
    $ASIX
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on AdvanSix with a new price target

    Piper Sandler initiated coverage of AdvanSix with a rating of Overweight and set a new price target of $58.00

    11/12/21 4:57:29 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    11/19/24 4:20:20 PM ET
    $ASIX
    Major Chemicals
    Industrials

    New insider Roberts Daryl claimed no ownership of stock in the company (SEC Form 3)

    3 - AdvanSix Inc. (0001673985) (Issuer)

    9/8/25 5:23:30 PM ET
    $ASIX
    Major Chemicals
    Industrials

    New insider O'Brien Dana C. claimed no ownership of stock in the company (SEC Form 3)

    3 - AdvanSix Inc. (0001673985) (Issuer)

    9/8/25 5:18:08 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SVP, General Counsel Kintiroglou Achilles B. sold $12,105 worth of shares (571 units at $21.20), decreasing direct ownership by 2% to 30,842 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    9/3/25 4:31:01 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Leadership Updates

    Live Leadership Updates

    View All

    AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Dana O'Brien and Daryl Roberts as new independent members of its Board of Directors. Ms. O'Brien recently retired as Senior Vice President and Chief Legal Officer of Olin Corporation, a leading vertically integrated global manufacturer and distributor of chemical products. Ms. O'Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee of the Board. Mr. Roberts is currently Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc., a global innovation leader with technology-based materials and solutions t

    9/2/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Appoints Sidd Manjeshwar as Senior Vice President and Chief Financial Officer

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Sidd Manjeshwar as Senior Vice President and Chief Financial Officer, effective October 1st. In this role, Mr. Manjeshwar will have global responsibility for controllership, treasury, investor relations, procurement, internal audit, commercial finance, tax and financial planning and analysis for the enterprise. Mr. Manjeshwar will report directly to Erin Kane, President and CEO of AdvanSix, and be a member of the Company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911629335/en/Sidd Manjeshwar, incoming SVP

    9/12/24 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Appoints Donald P. Newman to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Donald P. Newman as a new independent member of its Board of Directors. Mr. Newman is currently Executive Vice President, Finance and Chief Financial Officer of ATI Inc., a global producer of high-performance materials and solutions for the global aerospace and defense markets and critical applications in electronics, medical and specialty energy. Mr. Newman will serve on the Audit Committee and the Health, Safety and Environmental Committee of the Board of Directors. AdvanSix's Board now consists of nine members, including eight independent directors. "Don is well recognized for his financial expert

    8/19/24 4:30:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/13/24 4:55:58 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/9/24 9:58:57 AM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by AdvanSix Inc.

    SC 13G - AdvanSix Inc. (0001673985) (Subject)

    2/7/24 8:39:58 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Financials

    Live finance-specific insights

    View All

    AdvanSix Announces Second Quarter 2025 Financial Results

    2Q25 Sales of $410 million, down 10% versus prior year 2Q25 Earnings Per Share of $1.15; Adjusted Earnings Per Share of $1.24 2Q25 Cash Flow from Operations of $21 million $8 million of 45Q carbon capture tax credits claimed in 2Q25 AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the second quarter ending June 30, 2025. Overall, the Company delivered resilient earnings with strong sequential improvement and executed key growth and enterprise initiatives to support long-term sustainable performance. Second Quarter 2025 Summary "Our resilient second quarter results reflect our collective organization's execution and the advantages of

    8/1/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Second Quarter Financial Results and Hold Investor Conference Call on August 1

    AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its second quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, August 1. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's second quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on August 1 until 12 noon ET on August 8. You can listen to the replay by dialing (87

    7/11/25 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Announces First Quarter 2025 Financial Results

    1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

    5/2/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials